Preventive and therapeutic agents for dry eye in chronic graft-versus-host disease

摘要

It is intended to provide a medicinal composition for preventing and treating dye eye associated with chronic graft versus host disease (cGVHD) following the transplantation of hematopoietic stem cells. Namely, a medicinal composition or the like for preventing and treating dye eye associated with GVHD occurring after the transplantation of hematopoietic stem cells such as peripheral blood stem cell transplantation, cord blood transplantation or bone marrow transplantation which contains as the active ingredient N-(3,4-dimethoxycinnamoyl)anthranilic acid (common name: tranilast) or a pharmacologically acceptable salt thereof.